Henningsdorf
Germany
13
2011-02-17
9
2016-02-16
These are the the leading inventors for applications assigned to BRAHMS AKTIENGESELLSCHAFT:
BRAHMS AKTIENGESELLSCHAFT based in Henningsdorf, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Diagnosis and risk stratification using NT-proET-1
#2 | 2010-06-10 β Patent 8,252,544 granted on 2012-08-28Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients
#3 | 2010-04-15DIAGNOSIS AND RISK STRATIFICATION OF CARDIAC INSUFFICIENCY USING NEUROPHYSIN
#4 | 2010-02-25 β Patent 8,465,941 granted on 2013-06-18Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure
#5 | 2010-02-18 β Patent 8,158,368 granted on 2012-04-17Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
#6 | 2010-02-11 β Patent 8,436,135 granted on 2013-05-07Diagnosis and risk stratification by determining the marker CT-proADM
#7 | 2010-02-11DIAGNOSIS AND RISK ASSESSMENT OF PANCREATIC DIABETES USING MR-PROADM
#8 | 2010-02-04 β Patent 8,501,485 granted on 2013-08-06Risk stratification for acute coronary syndrome by determining copeptin
#9 | 2008-09-18METHOD AND AGENT FOR THE PREVENTION, INHIBITION AND TREATMENT OF SEPSIS
#10 | 2006-12-26 β Patent 7,153,662 granted on 2006-12-26Inflammation-specific peptides and the uses thereof
#11 | 2006-02-16Method and agents for the prevention, inhibition and therapy of cancers
#12 | 2005-04-07 β Patent 7,358,058 granted on 2008-04-15Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease
#13 | 2005-03-17 β Patent 7,572,590 granted on 2009-08-11Method for the diagnosis of sepsis with determination of CA 19-9
212285 β